164 related articles for article (PubMed ID: 18556884)
21. Hereditary breast/ovarian cancer--pitfalls in genetic counseling.
Dagan E; Gershoni-Baruch R
Clin Genet; 2001 Oct; 60(4):310-3. PubMed ID: 11683778
[TBL] [Abstract][Full Text] [Related]
22. Hereditary breast and ovarian cancer syndrome and issues in pediatric and adolescent practice.
Herman JD; Appelbaum H
J Pediatr Adolesc Gynecol; 2010 Aug; 23(4):253-8. PubMed ID: 20632459
[No Abstract] [Full Text] [Related]
23. Contribution of BRCA2 germline mutations to hereditary breast/ovarian cancer in Germany.
Hamann U; Liu X; Lange S; Ulmer HU; Benner A; Scott RJ
J Med Genet; 2002 Mar; 39(3):E12. PubMed ID: 11897832
[No Abstract] [Full Text] [Related]
24. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
25. Breast & ovarian cancer. Issues in risk assessment.
Caro SW
Adv Nurse Pract; 1999 Aug; 7(8):26-32; quiz 33-4. PubMed ID: 10745719
[No Abstract] [Full Text] [Related]
26. Receiving inconclusive genetic test results: an interpretive description of the BRCA1/2 experience.
Maheu C; Thorne S
Res Nurs Health; 2008 Dec; 31(6):553-62. PubMed ID: 18449940
[TBL] [Abstract][Full Text] [Related]
27. Familial breast and ovarian cancer: genetic counseling and clinical management in Italy.
Pasini B; Pierotti MA
Dis Markers; 1999 Oct; 15(1-3):41-3. PubMed ID: 10595250
[No Abstract] [Full Text] [Related]
28. Genomic rearrangements in the BRCA1 and BRCA2 genes.
Mazoyer S
Hum Mutat; 2005 May; 25(5):415-22. PubMed ID: 15832305
[TBL] [Abstract][Full Text] [Related]
29. Unprepared, understaffed, and unplanned: thoughts on the practical implications of discovering new breast and ovarian cancer causing genes.
Resta RG
J Genet Couns; 2009 Dec; 18(6):521-3. PubMed ID: 19798552
[No Abstract] [Full Text] [Related]
30. [Inherited breast and ovarian cancers].
Gerdes AM; Ejlertsen B
Ugeskr Laeger; 2006 Jun; 168(24):2367-9. PubMed ID: 16822422
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.
Leegte B; van der Hout AH; Deffenbaugh AM; Bakker MK; Mulder IM; ten Berge A; Leenders EP; Wesseling J; de Hullu J; Hoogerbrugge N; Ligtenberg MJ; Ardern-Jones A; Bancroft E; Salmon A; Barwell J; Eeles R; Oosterwijk JC
J Med Genet; 2005 Mar; 42(3):e20. PubMed ID: 15744030
[No Abstract] [Full Text] [Related]
32. Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer.
Dombernowsky SL; Weischer M; Freiberg JJ; Bojesen SE; Tybjaerg-Hansen A; Nordestgaard BG
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2339-42. PubMed ID: 19661094
[TBL] [Abstract][Full Text] [Related]
33. Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer.
Robson ME
Cancer Control; 2002; 9(6):457-65. PubMed ID: 12514563
[TBL] [Abstract][Full Text] [Related]
34. The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation.
Sermijn E; Goelen G; Teugels E; Kaufman L; Bonduelle M; Neyns B; Poppe B; De Paepe A; De Grève J
J Med Genet; 2004 Mar; 41(3):e23. PubMed ID: 14985394
[No Abstract] [Full Text] [Related]
35. BRCA1: genetic testing and hereditary breast and ovarian cancer.
Ross DW
Arch Pathol Lab Med; 1997 Jul; 121(7):754-5. PubMed ID: 9240915
[No Abstract] [Full Text] [Related]
36. [Management of families at high risk for hereditary breast-ovarian cancers: the endocrinologist's point of view].
Courtillot C; Touraine P
Ann Endocrinol (Paris); 2008 Jun; 69(3):193-200. PubMed ID: 18294609
[TBL] [Abstract][Full Text] [Related]
37. Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.
de la Hoya M; Osorio A; Godino J; Sulleiro S; Tosar A; Perez-Segura P; Fernandez C; Rodríguez R; Díaz-Rubio E; Benítez J; Devilee P; Caldés T
Int J Cancer; 2002 Feb; 97(4):466-71. PubMed ID: 11802208
[TBL] [Abstract][Full Text] [Related]
38. 'Polygenic' analyses may sharpen disease risk predictions.
Kaiser J
Science; 2019 Dec; 366(6472):1431. PubMed ID: 31857459
[No Abstract] [Full Text] [Related]
39. BRCA1 and BRCA2 cancer risks.
Antoniou AC; Pharoah PD; Easton DF; Evans DG
J Clin Oncol; 2006 Jul; 24(20):3312-3; author reply 3313-4. PubMed ID: 16829658
[No Abstract] [Full Text] [Related]
40. Diagnostic criteria for testing for BRCA1 and BRCA2: the experience of the Department of Defense Familial Breast/Ovarian Cancer Research Project.
Fries MH; Holt C; Carpenter I; Carter CL; Daniels J; Flanagan J; Murphy K; Hailey BJ; Martin L; Hume R; Hudson G; Cadman M; Weatherly R; Nunes ME
Mil Med; 2002 Feb; 167(2):99-103. PubMed ID: 11873550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]